About Gene Thrive
Advancing Innovation, Transforming Lives: The Future of Gene Therapy Starts Here
Step into GeneThrive, where groundbreaking ideas ignite progress in the fast-evolving world of gene therapy. This top-tier summit is all about sparking collaboration, fueling creativity, and pushing genetic medicine to new heights.
GeneThrive unites a dynamic mix of scientists, clinicians, entrepreneurs, investors, and policymakers—bound by a common mission to transform healthcare through the power of genes. It’s a lively hub where visionaries and pioneers swap insights, unveil the latest research, and dive into the trends defining gene therapy’s future.
Built on inclusivity and cross-disciplinary teamwork, GeneThrive creates a welcoming space for experts to tackle big challenges and seize bold opportunities. With compelling keynotes, hands-on workshops, sharp panel debates, and prime networking moments, GeneThrive equips attendees to innovate fearlessly, break barriers, and shape the next chapter of genetic medicine.
Join us at GeneThrive 2025 for a game-changing experience—where innovation thrives, connections deepen, and the future of gene therapy takes shape. Unite with bold visionaries dedicated to advancing science, conquering obstacles, and redefining healthcare.
Gene Thrive 2025 Speakers
Avencia Sánchez Mejías
Co-Founder & Chief Executive Officer, Integra Therapeutics
FiCAT, a gene-writing platform for advanced cell-engineering
Eric B. Kmiec
Executive Director & Chair, Gene Editing Institute
TBA
Kevin Davies
Executive Editor, The CRISPR Journal
TBA
Mark A. Kay
Stanford University
Genome engineering with Cas9 and AAV repair templates generates frequent concatemeric insertions of viral vectors
Limor Davidson Mund
Vice President Business Development, PlantArcBio
TBA
Faryan Tayyari
Director, Clinical Development Strategy Lead, Boehringer Ingelheim
TBA
John Engelhardt
Professor of Anatomy and Cell Biology, University of Iowa
Durable transgene expression and efficient re-administration after rAAV2.5T-mediated fCFTRΔR gene delivery to adult ferret lungs
Delphine Agathon
Senior Director & Category Clinician, Pfizer
Clinical Trial Designs for Immunogenicity Assessments
Why Attend Gene Thrive 2025
GeneThrive 2025 offers a unique opportunity for professionals across various sectors to come together and participate in a transformative event focused on gene therapy. Here are several compelling reasons why individuals should attend:
Stay Updated on the Latest Advancements
Gene Thrive provides access to cutting-edge research and breakthrough technologies.
Networking and Collaboration
A platform for networking and collaboration among industry leaders, researchers, and other stakeholders.
Professional Development
Gain invaluable insights and skills through keynote presentations, discussions, and interactive sessions.
Access to Expertise
Engage with experts, thought leaders, and key opinion leaders in the gene therapy field.
Influence and Impact
Influence the direction of gene therapy advancements and policy shaping future developments.
Inspiration and Motivation
Be inspired by innovative research and patient success stories, fueling your own passion in the field.
Agenda at a Glance
CRISPR and Beyond: Innovations in Gene Editing
This session will delve into the latest advancements in gene editing technologies, including CRISPR/Cas9, base editing, and prime editing. Experts will discuss their applications in therapeutic development, challenges, and future prospects.
Precision Gene Editing with Base Editors
Explore base editing, the game-changer enabling pinpoint single-nucleotide tweaks without risky double-strand breaks. Experts will break down its mechanics, spotlight its role in drug development, and weigh its limits—plus tease recent leaps and where it’s headed.
Prime Editing: Rewriting the Genetic Code
Get the inside track on prime editing, a breakthrough tech rewriting DNA with surgical precision—insertions, deletions, or swaps, no compromises. Leaders will reveal how it works, its therapeutic potential, and the challenges ahead, showcasing why it’s a big deal for the industry.
Next-Generation Gene Editing Platforms
Discover the cutting-edge tools pushing beyond CRISPR—think homing endonucleases, transposon systems, and synthetic nucleases. This subsession spotlights how these platforms are reshaping research and therapies, with insights into their practical impact and future promise.
Viral Vectors: Engineering the Perfect Carrier
Dive into viral vectors, the workhorses of gene therapy delivery. Experts will unpack cutting-edge engineering tricks—boosting safety, dodging immune blowback, and maxing out efficiency—while confronting the real-world hurdles holding them back.
Non-Viral Delivery Systems
Explore the rising stars of gene delivery—liposomes, nanoparticles, polymers, and cell-penetrating peptides. Leaders will weigh their edge over viral options, dissect limitations, and showcase breakthroughs that amp up targeting and payload punch.
Genome Editing Delivery: CRISPR Carriers
Get the lowdown on delivering CRISPR-Cas systems for precision edits. This subsession covers viral and non-viral strategies, spotlighting how to optimize for target cells, sidestep pitfalls, and unlock CRISPR’s full therapeutic potential.
Targeted Delivery: Precision Medicine Approaches:
Crack the code on hitting the bullseye with gene therapies. Experts will dive into ligand-guided targeting, tissue-specific promoters, and other precision tactics—showing how to sharpen specificity, cut off-target noise, and boost clinical impact.
Genetic Disorders: Therapeutic Breakthroughs:
Dive into gene therapy’s impact on genetic disorders—think cystic fibrosis, muscular dystrophy, and sickle cell disease. Experts will reveal recent wins, unpack active trials, and tackle the leap from preclinical promise to bedside reality.
Cancer Immunotherapy: Targeting Tumor Cells: Advances in Base Editing:
Explore gene therapy’s arsenal against cancer—CAR-T cells, adoptive transfers, and oncolytic viruses. Leaders will break down cutting-edge advances, clinical results, and the next wave of strategies to wipe out tumors with precision.
Neurodegenerative Diseases: Promising Interventions:
Unlock gene therapy’s potential for neurodegenerative foes like Parkinson’s, Alzheimer’s, and ALS. This subsession digs into novel delivery tactics, editing tools, and emerging targets aimed at halting these diseases at their roots.
Infectious Diseases: Gene-Based Strategies:
Fight back against infections—viral, bacterial, and beyond—with gene therapy. Experts will showcase gene-driven vaccines, antivirals, and immune boosts, plus explore how editing can outsmart pathogens and fortify host defenses.
Informed Consent and Autonomy
Unpack the messy reality of consent in gene therapy trials. Leaders will tackle how to secure genuine buy-in, clarify risks versus rewards, and shield vulnerable groups—ensuring trials don’t just push science but respect patients.
Equity and Access
Face the hard truth about who gets gene therapies—and who doesn’t. Experts will dissect barriers like sky-high costs, spotty insurance, and uneven healthcare systems, pitching bold fixes to level the playing field for all patients.
Privacy and Genetic Data
Dive into the minefield of genetic data—privacy risks, security gaps, and legal gray zones. This subsession spotlights how to safeguard sensitive info, meet regs, and steward data responsibly in research and practice.
Social and Cultural Implications
Explore how society views gene therapy—hype, fear, or something else? Experts will decode cultural drivers of acceptance or pushback, sharing ways to build trust and inclusivity across research, education, and care.
Next-Generation Therapeutic Modalities:
Uncover the tools rewriting gene therapy’s playbook—RNA therapies, in vivo editing, and synthetic biology. Experts will spotlight their game-changing potential, real-world applications, and the hurdles to bringing them to market.
Personalized Medicine and Gene Editing:
See how gene editing meets precision medicine head-on. Leaders will dive into genome sequencing breakthroughs, biomarker wins, and patient-tailored edits—showing how to craft therapies as unique as the people they treat.
Gene Therapy for Rare Diseases:
Tackle rare diseases with gene therapy’s firepower. This subsession digs into fast-tracking solutions for unmet needs—think streamlined regs, patient advocacy, and team-ups that turn orphan drugs into reality.
Regulatory and Policy Landscape:
Navigate the shifting rules and red tape of gene therapy. Experts will break down regulatory roadblocks, policy shifts, and what’s coming next to keep innovation safe, ethical, and on track for the clinic.
Interested in Sponsoring Gene Thrive 2025?
If your company is interested in sponsoring Gene Thrive 2025, we would be delighted to discuss the opportunities with you. Please send us a quick email, and we will promptly provide you with more information and our sponsorship brochure.
Sponsors
Gene Thrive 2025: Advancing Innovation, Transforming Lives: The Future of Gene Therapy Starts Here
Contact
Address
259, Narendra Colony, Hyderabad, Telangana 502032
Call Us
+91 9059841607
Email Us
jyothi@pharmasynergevents.com
Our Newsletter
Subscribe to our newsletter and receive the latest news about our products and services!